CureVac

German bio-pharmaceutical company

CureVac N.V. is a German biopharmaceutical company, legally domiciled in the Netherlands and headquartered in Tรผbingen, Germany, that develops therapies based on messenger RNA (mRNA). The company's focus is on developing vaccines for infectious diseases and drugs to treat for cancer and rare diseases. Founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Gรผnther Jung and Hans-Georg Rammensee, CureVac had approximately 240 employees in November 2015 and 375 in May 2018.

CureVac News and Videos   LIVE

โ„น๏ธ This is a LIVE page which updates automatically as we're monitoring our hand-curated selection of verified and trustworthy media outlets

You might like